Arcturus Therapeutics Holdings Inc (ARCT) — Capital Reinvestment Ratio
Arcturus Therapeutics Holdings Inc (ARCT) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow ($50.81 Million) in capital expenditures ($354.00K). See debt-free asset ratio of Arcturus Therapeutics Holdings Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Arcturus Therapeutics Holdings Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Arcturus Therapeutics Holdings Inc's Capital Reinvestment Ratio across 1 annual periods. Check Arcturus Therapeutics Holdings Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Arcturus Therapeutics Holdings Inc from 2022 to 2022. For live market cap and broader valuation context, see ARCT stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.24x | $31.99 Million | $7.73 Million | — |